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Abstract
Purpose The purpose of this study is to assess the psychomet-
ric properties of the Dutch version of the 34-item Short-Form
Supportive Care Needs Survey (SCNS-SF34) and the newly
developed module for head and neck cancer (HNC) patients
(SCNS-HNC).
Methods HNC patients were included from two cross-sectional
studies. Content validity of the SCNS-HNC was analysed by
examining redundancy and completeness of items. Factor struc-
ture was assessed using confirmatory and exploratory factor
analyses. Cronbach’s alpha, Spearman’s correlation, Mann–
WhitneyU test, Kruskall–Wallis and intraclass correlation coef-
ficients (ICC) were used to assess internal consistency, construct
validity and test–retest reliability.
Results Content validity of the SCNS-HNCwas good, although
some HNC topics were missing. For the SCNS-SF34, a four-
factor structure was found, namely physical and daily living,
psychological, sexuality and health system and information
and patient support (alpha = .79 to .95). For the SCNS-HNC,
a two-factor structure was found, namely HNC-specific func-
tioning and lifestyle (alpha = .89 and .60). Respectively, 96 and
89 % of the hypothesised correlations between the SCNS-SF34
or SCNS-HNC and other patient-reported outcome measures
were found; 57 and 67 % also showed the hypothesised magni-
tude of correlation. The SCNS-SF34 domains discriminated be-
tween treatment procedure (physical and daily living p = .02 and
psychological p = .01) and time since treatment (health system,
information and patient support p = .02). Test–retest re-
liability of SCNS-SF34 domains and HNC-specific func-
tioning domain was above .70 (ICC = .74 to .83), and
ICC = .67 for the lifestyle domain. Floor effects ranged
from 21.1 to 70.9 %.
Conclusions The SCNS-SF34 and SCNS-HNC are valid and
reliable instruments to evaluate the need for supportive care
among (Dutch) HNC patients.
Keywords Head and neck cancer . Supportive care needs .
Reliability . Validity . Psychometric characteristics . Internal
consistency
Introduction
Head and neck cancer (HNC) patients often experience gener-
ic cancer-related problems, such as pain, fatigue [1], anxiety
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[2] and depression [3] as well as HNC-specific problems such
as dysphagia [4], or problems with speech [5], nutrition [6]
and hearing [7], influencing their quality of life [1, 6].
Supportive care (SC), defined as the prevention and manage-
ment of adverse effects of cancer and its treatment [8], can
help improve these problems.
In order to provide adequate SC tailored to patients’wishes
and needs, insight into their perceived need for SC is required.
A frequently used patient-reported outcome measure (PROM)
on generic cancer-related SC needs is the 34-item Short-Form
Supportive Care Needs Survey (SCNS-SF34). The SCNS-
SF34 measures the need and level of need for SC, in-
cluding physical and daily living, psychological, sexual-
ity, patient care and support and health system and in-
formation needs [9, 10].
Currently, the SCNS-SF34 has been translated and validat-
ed in English [9, 11], French [12], German [13], Italian [14],
Mexican [15], Chinese [16, 17] and Japanese [18] popula-
tions, including breast [12, 16, 18], colorectal [17], prostate
[11] andmixed [9, 13–15] cancer patients. ADutch translation
of the SCNS-SF34 has not been validated so far. In addition,
the SCNS-SF34 has not yet been validated among HNC pa-
tients. Cross validation of PROMs, when translated into a
different language or used in a different cancer population, is
of importance, since lingual, cultural and population differ-
ences may affect psychometric characteristics.
Supplementary modules for use in conjunction with the
SCNS-SF34 have been developed to measure SC needs spe-
cific for breast [19, 20], melanoma [21] and prostate [22]
cancer patients. Henry et al. [23] added four items (alcohol
cessation, smoking cessation, feeling better about my appear-
ance and finding meaning and purpose in life) to the SCNS-
SF34, which were expected to be relevant to HNC patients;
however, these items were not validated. Therefore, we devel-
oped an HNC-specific module (SCNS-HNC) by multidisci-
plinary team discussions consisting of a physician, speech
pathologist, linguist, psychologist and health scientist, which
we previously used to identify cutoff scores on the European
Organisation for Research and Treatment of Cancer (EORTC)
head and neck cancer-specific quality of life questionnaire
(EORTC QLQ-H&N35) [24].
The aim of this study was to assess the psychometric prop-
erties (i.e. internal consistency, validity and test–retest reliabil-
ity) of the Dutch version of the SCNS-SF34 and SCNS-HNC
in HNC patients.
Patients and methods
Design and study participants
Patients were included from two cross-sectional studies con-
ducted at the Department of Otolaryngology—Head and Neck
Surgery of the VU University Medical Center (VUmc),
Amsterdam, The Netherlands. The first study included HNC
patients who visited the department from April to September
2013 and who participated in an evaluation study of a touch
screen computer-assisted PROM system, which is part of stan-
dard clinical practice (called OncoQuest) [25]. After complet-
ing OncoQuest, all eligible patients were asked to fill in a
questionnaire at home using paper and pencil (including the
SCNS-SF34 and SCNS-HNC). In addition, all patients who
discussed the results of OncoQuest with an oncology nurse
(also part of standard clinical practice) were asked whether
they agreed to have a researcher present during this nursing
consultation. The researcher completed a study-specific report
form regarding this consultation.
The second study included HNC patients who visited the
department in February or March 2015. All eligible patients
were asked to fill in a questionnaire at home using paper and
pencil (including the SCNS-SF34 and SCNS-HNC). In addi-
tion, all patients who completed the first questionnaire in this
second study were asked to complete the SCNS-SF34 and
SCNS-HNC a second time 1–2 weeks later (for test–retest
analyses).
Completed questionnaires were sent back to VUmc. In case
of missing data, clarifications were sought over the telephone.
Patients were included in this particular study when they (1)
were treated with curative intent for cancer of the oral cavity,
pharynx, larynx, nasal cavity or major salivary glands; (2)
were between 3 months and 5 years after last treatment; and
(3) were ≥18 years old. Patients were excluded when they had
cognitive impairments or did not understand the Dutch lan-
guage. According to the Dutch Medical Research Involving
Human Subjects Act, ethical approval was not necessary, be-
cause patients were not subjected to procedures or required to
follow rules of behaviour.
Measures
SCNS-SF34
The SCNS-SF34 measures the need and level of need for SC
in the last month on 34 items on a five-point, two-level re-
sponse scale [9, 10]. The first response scale consists of two
broad categories of need, i.e. ‘no need’ and ‘need’. The ‘no
need’ scale is further subdivided into ‘not applicable’ for is-
sues that were no problem to the patient, and ‘satisfied’ for
issues on which a patient needed support but the support was
satisfactory. The ‘need’ category has three subcategories indi-
cating the level of need for additional care, namely ‘low need’,
‘moderate need’ and ‘high need’. According to the original
study of Boyes et al. [9] among mixed cancer patients, SC
needs can be subdivided into the following five underlying
domains: physical and daily living, psychological, sexuality,
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patient care and support and health system and information.
An alternative factor structure was suggested by Au et al. [16]
among breast cancer patients, who found four underlying do-
mains using 33 items: physical and daily living, psychologi-
cal, sexuality and health system, information and patient sup-
port. A total score per domain can be calculated and converted
to a standardized 0–100 score, with a higher score indicating a
higher level of need [10].
The SCNS-SF34 was translated into Dutch according to
the EORTC guideline [26]. A translator and a nurse specialist
(both Dutch native speakers) translated the SCNS-SF34 into
Dutch. The translations were compared by two of the authors
(FJ and IV), and slight discrepancies were solved by discus-
sion in order to provide one Dutch version. By means of back
translation, the Dutch version was converted into English by
two independently working native English-speaking persons
and compared by the two authors to the original English
version.
SCNS-HNC
The SCNS-HNC measures the need for SC concerning 11
HNC-specific issues using the same response scale as the
SCNS-SF34. In addition, a single free-text item was added,
where patients could report any additional needs, which were
not yet taken into account in the SCNS-SF34 or SCNS-HNC.
This free-text item was added to analyse whether supportive
care needs were missing from the patient perspective. Reading
age of the SCNS-HNC calculated using the formula of Douma
(formula of Flesch–Kincaid Grade adjusted for Dutch situa-
tion) was 13–15 years [27].
Other PROMs and clinical measures
All HNC patients also completed the EORTC generic
(EORTC QLQ-C30) [28] and HNC-specific (EORTC QLQ-
H&N35) [29] quality of life measure, the Hospital Anxiety
and Depression Scale (HADS) [30], the speech handicap in-
dex (SHI) [31] and a PROM evaluating swallowing problems
(SWAL-QOL) [32]. In the first study, these PROMs were
completed using OncoQuest [25], while in the second, study
they were assessed concurrently with the SCNS-SF34 and
SCNS-HNC.
Besides, in the first study, a study-specific report form was
completed by an observing researcher, who was present dur-
ing the nursing consultation following OncoQuest. This report
form included information on topics, information and SC op-
tions discussed during the nursing consultation.
Finally, socio-demographic characteristics were patient-re-
ported, and clinical characteristics were retrieved from pa-
tients’ medical records.
Data analyses
Content validity of the SCNS-HNC was analysed by examin-
ing redundancy and completeness of items. Items were con-
sidered redundant if <10 % of the patients reported a need (or
in case of SCNS-HNC item 6, <10% of patients were treated
with total laryngectomy). Completeness of the SCNS-HNC
was examined by analysing SC needs reported on the free-
text item of the SCNS-HNC and analysing needs discussed
during the nursing consultation as assessed in the study-
specific report form. If ≥5 % of patients reported or discussed
an additional SC need, adding this specific need to the SCNS-
HNC should be considered.
Confirmatory factor analysis was used to analyse whether
the original five-factor [9] or alternative four-factor structure
[16] of the SCNS-SF34 could be replicated, as proposed by
Terwee et al. [33]. Criteria for an acceptable fit were root mean
square error of approximation (RMSEA) <.06, comparative fit
index (CFI) and Tucker–Lewis index—non-normed fit index
≥.9. Principal component analysis with varimax rotation of
factors with eigenvalues >1.0 was used to analyse the factor
structure of the SCNS-HNC. Appropriateness of principal
component analysis was examined using Bartlett’s test of
sphericity (p < .05) and the Kaiser, Meyer Olkin index of
sampling adequacy (KMO ≥ .60). Internal consistency was
assessed using Cronbach’s alpha coefficient, that is, a value
between .70 and .95 is considered good [33].
To analyse construct validity, a priori hypotheses were for-
mulated regarding the correlation between the SCNS-SF34
(31 hypotheses) or SCNS-HNC (9 hypotheses) and other
PROMs (EORTC QLQ-C30, EORTC QLQ-H&N35,
HADS, SHI and SWAL-QOL; presented in Table 1) and ex-
pected differences between groups of HNC patients (13 hy-
potheses). Hypotheses were based on previous studies [9,
11–13, 16, 18, 34–36] and researchers’ expectations.
Regarding expected differences, it was expected that (1) youn-
ger patients (18–60 years) reported a higher level of need than
older patients (>60 years) on all domains except for physical
and daily living [12, 13, 16, 18, 35]; (2) females reported a
higher level of need on the physical and daily living and psy-
chological domain [13], while males reported a higher level of
need on the sexuality domain [13, 35]; (3) patients with
multimodality treatment reported a higher level of need on
all domains but sexuality than patients who received single
treatment; and (4) patients long after treatment reported a low-
er need on the patient care and support and health system and
information domains [36]. Correlations were analysed using
Spearman’s correlation coefficient, since needs were non-
normal distributed. Magnitude of the correlations were de-
fined as moderate (r = 0.30 to 0.50) or strong (r > 0.50)
[37]. Differences between groups of HNC patients were
analysed using Mann–Whitney U test or Kruskall–Wallis. A
p value of <.05 was considered statistically significant. The
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SCNS-SF34 and/or SCNS-HNC were found to be valid if at
least 75 % of the hypotheses were in correspondence with the
a priori defined hypotheses [33].
Test–retest reliability was analysed using intraclass corre-
lation coefficients (ICC) with absolute agreement in patients
who completed the second questionnaire within 1 month after
the first. An ICC value ≥.70 has been considered good [33].
Finally, floor or ceiling effects (>15 % of patients with the
lowest or highest possible score) were investigated using fre-
quency tables.
All analyses were performed using the IBM Statistical
Package for the Social Science (SPSS) version 22 (IBM
Corp., Armonk, NY, USA) and Mplus version 6.11 (Muthen
& Muthen, Los Angeles, CA, USA) [38].
Sample size calculation
For this study, at least 170 patients were needed for factor
analyses (five times the number of SCNS-SF34 items), 50
Table 1 A priori defined hypotheses regarding the (magnitude of the) correlation of domains of the SCNS-SF34 and items of the SCNS-HNC with
other patient-reported outcome measures and the found correlation
SCNS-SF34 SCNS-HNC













Anxiety .48a .65b .34a .51a a




Emotional functioning −.56c −.64d −.47c c
Cognitive functioning −.43c −.47c
Social functioning −.54c
Global quality of life −.55d −.51c
















SHI total score .64b
If the a priori defined hypothesis was supported, the coefficient was italicized
P&DL physical and daily living, PSY psychological, SEX sexuality, PC&S patient care and support, HS&I health system and information
a A positive moderate (r = .30–.50) association was expected
bA positive strong (r > .50) association was expected
c A negative moderate (r = −.30 to −.50) association was expected
dA negative strong (r < −.50) association was expected
e Since a four-factor structure was found, we only present correlations of the combined HIS&PS domain
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patients per subgroup for construct validity analyses and 50
patients for test–retest reliability [33].
Results
Study sample
In total, 201 patients were included for content analyses, factor
analyses and construct validity analyses; 110 patients for test–
retest analyses; and 69 patients for content analysis using the
study-specific report forms. Socio-demographic and clinical
characteristics are presented in Table 2.
Content validity of the SCNS-HNC
On all SCNS-HNC items, ≥10 % of the patients reported a
need, indicating that there were no redundant items.
Regarding completeness, two of the 201 patients who filled
in the SCNS-HNC reported on the free-text item that they had
an additional need not yet taken into account in the question-
naire, one indicated to have needs regarding pain and one
regarding psychological distress. The study-specific report
form of the nursing consultation following OncoQuest re-
vealed some frequently discussed HNC-specific issues not
yet included in the SCNS-HNC, namely coughing and breath-
lessness (23 %), difficulty eating or eating in company (19%),
taste and olfaction (16 %), changes in appetite (9 %) and
mobility of the tongue (6 %).
Factor analysis and internal consistency
The five-factor structure as well as the four-factor structure of
the SCNS-SF34 could not be replicated in our study sample
using confirmatory factor analysis (see supplementary
materials). Under the assumption either of correlated factors
or of uncorrelated factors, both factor structures had a negative
residual variance on item 16 ‘changes in your sexual relation-
ships’. Therefore, we also performed an analysis, in which
item 16 was deleted. In that case, both factor models could
not be estimated when assuming correlated factors. When
assuming correlated factors, both factor models showed inad-
equate RMSEA scores. Therefore, an exploratory principal
component analysis was performed to investigate the factor
structure for use in HNC patients. At first, a new five-factor
structure was generated (see supplementary materials), repli-
cating the physical and daily living and sexuality domains and
almost replicating the psychological needs and health system,
information and patient support domain as reported in Au
et al. [16]. However, the fifth factor comprised four items
(item 17–19 and 24) without clear cohesion. Since three out
of these four items had high cross loadings (cross loadings .34
to .51), a second principal component analysis was performed
without item 19 (which did not have any cross loadings) and
forced into four factors, resulting in the same factor structure
as in Au et al. [16]. Although this four-factor structure
(Bartlett’s test of sphericity (p < .001) and KMO = .93) did
not have a good fit of the model using confirmatory factor
analyses, this model is nevertheless proposed to be the best
model for use in HNC patients with good internal consistency
(Cronbach’s alpha ranging from .79 (sexuality domain) to .95
(psychological)) (Table 3).
Principal component analysis of the SCNS-HNC showed
two underlying constructs, namely HNC-specific functioning
and lifestyle (Bartlett’s test of sphericity (p < .001) and
KMO= .88) (Table 4). Item 6was not included in the principal
component analysis, since it was not correlated (r < .30) with
the other items. Internal consistency of HNC-specific func-
tioning domain was good (Cronbach’s alpha = .89), while
below .70 for the two-item lifestyle domain (Cronbach’s
alpha = .60).
Construct validity
In total, 27 of the 28 (96 %) hypothesised correlations (seven
hypotheses on health system, information and patient support
were investigated instead of 11 hypotheses when the five-
factor structure would have been replicated) between the
SCNS-SF34 and other PROMs were found (Table 1).
Sixteen correlations (57 %) also supported the a priori
hypothesised magnitude of correlation. Regarding expected
differences, three of the ten hypotheses were confirmed
(30 %; Table 5). Patients treated with multi-modality treat-
ment reported a higher need on the physical and daily living
(p = .015) and psychological domain (p = .009), while no
difference was found for health system, information and pa-
tient support (p = .070). Patients long after treatment reported
less need for health system, information and patient support
than patients short after treatment (p = .015). No significant
differences were found regarding gender or age.
Of the SCNS-HNC, 8 of the 9 (89 %) hypothesised corre-
lations were found (Table 1). Six correlations (67 %) also
supported the a priori hypothesised magnitude of correlation.
Test–retest reliability
Test–retest reliability of the SCNS-SF34 domains was good
(ICC ranged from .74 (sexuality) to .83 (physical and daily
living)). Test–retest reliability for HNC-specific functioning
was also good (ICC = .83), while it was slightly lower than
.70 for the lifestyle domain (ICC = .67).
Presence of floor and/or ceiling effects
On all SCNS-SF34 and SCNS-HNC domains, floor effects
were present (Tables 3 and 4). Floor effects (no need for care)
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Table 2 Characteristics of the
study samples Characteristics Factor analyses and









18–60 years 31.3 25.5 46.4
>60 years 68.7 74.5 53.6
Sex
Male 66.7 72.7 63.8
Female 33.3 27.3 36.2
Living arrangements
Living alone 24.4 30.0 14.3a
Living with partner 58.7 59.1 59.2
Living with partner and children 15.4 10.0 22.4
Other (e.g. with children) 1.5 .9 4.1
Education
Elementary education 6.5 3.6 5.8a
Lower education 37.8 40.0 24.6
Secondary education 26.9 25.5 23.2
Higher education 28.9 30.9 17.4
Employment status
Employed (paid/unpaid) 35.8 30.9 42.9a
Unemployed 12.5 11.8 16.3
Housewife/houseman 3.5 3.6 4.1
Retired 48.3 53.6 36.7
Tumour site
Oral cavity 31.3 33.6 30.4
Pharynx 36.8 35.5 36.2
Larynx 19.9 20.9 17.4
Nasal cavity 6.0 4.5 8.7
Major salivary glands 6.0 5.5 7.2
Disease stage (UICC)
Stage I 27.9 30.9 23.2
Stage II 13.4 10.0 21.7
Stage III 16.4 16.4 18.8
Stage IV 36.8 34.5 34.8
Unknown 5.5 8.2 1.4
Type of treatment
Surgery 25.4 25.5 27.5
Radiotherapy 20.4 21.8 23.2
Surgery and chemoradiation 8.5 7.3 5.8
Surgery and radiation 22.4 22.7 23.2
Chemoradiation 23.4 22.7 20.3
Time since last treatment
<1 year 38.8 34.5 44.9
1–2 year 29.9 31.8 26.1
>2 year 31.3 33.6 29.0
a Living arrangement, education and employment status are missing in 20 patients
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1 2 3 4
Physical and daily living 38.8 0
1. Pain 70.9 2.5 .39 .54
2. Lack of energy/tiredness 51.0 4.5 .33 .51 .60
3. Feelings unwell a lot of the time 74.6 1.0 .53 .67
4. Work around the home 58.4 3.0 .76
5. Not being able to do the things you used to do 57.7 7.5 .39 .39 .69
Psychological 29.7 0
6. Anxiety 68.0 2.5 .78 .31
7. Feeling down or depressed 67.7 1.0 .32 .78
8. Feelings of sadness 66.7 2.0 .81
9. Fears about the cancer spreading 51.5 8.5 .85
10. Worry that the results of treatment are beyond your control 59.7 3.5 .34 .74
11. Uncertainty about the future 50.0 5.5 .33 .82
12. Learning to feel in control of your situation 58.0 1.5 .35 .68 .41
13. Keeping a positive look 54.2 3.5 .31 .52 .42
14. Feelings about death and dying 65.0 4.5 .79
17. Concerns about the worries of those close to you 60.5 2.5 .38 .42 .30
Sexuality 69.9 .5
15. Changes in sexual feelings 75.3 3.0 .48 .74
16. Changes in your sexual relationships 77.8 2.5 .36 .84
31. To be given information about sexual relationships 85.4 .5 .76
Health system, information and patient support 21.1 0
18. More choice about which cancer specialists you see 67.5 1.5 .47 .41
20. Reassurance by medical staff that the way you feel is normal 43.5 2.5 .62 .34 .31
21. Hospital staff attending promptly to your physical needs 57.5 2.0 .73
22. Hospital staff acknowledging, and showing sensitivity to your feelings and emotional needs 55.0 1.5 .75
23. Being given written information about the important aspects of your care 58.0 2.0 .75
24. Being given information (written, diagrams, drawings) about aspects of managing your illness
and side effects at home
61.5 4.0 .65 .30
25. Being given explanations of those tests for which you would like explanations 46.2 2.5 .72 .31
26. Being adequately informed about the benefits and side effects of treatments before you choose
to have them
47.2 4.5 .79
27. Being informed about your test results as soon as feasible 43.3 11.9 .74 .31
28. Being informed about cancer which is under control or diminishing (that is, remission) 38.3 10.4 .77 .37
29. Being informed about things you can do to help yourself to get well 50.2 8.5 .78 .30
30. Having access to professional counselling (e.g. psychologist, social worker, counsellor, nurse
specialist) if you, your family or friends need it
66.7 4.5 .67 .35
32. Being treated like a person not just another case 53.2 9.5 .79
33. Being treated in a hospital or clinic that is as physically pleasant as possible 44.3 6.5 .72
34. Having one member of hospital staff with whom you can talk to about all aspects of your
condition, treatment and follow-up
47.3 6.5 .78
19. More choice about which hospital you attend 68.5 2.0 – – – –
Eigenvalue 16.69 3.34 1.67 1.23
Variance 50.58 10.11 5.05 3.71
Cronbach’s α .95 .95 .89 .79
a Loadings >.3 are presented, and main (i.e. highest) loading is italicized
Support Care Cancer (2016) 24:4639–4649 4645
ranged from 21.1 % (health system, information and patient
support) to 70.9 % (lifestyle). No ceiling effects were present.
Discussion
This study is the first study that investigated the psychometric
properties of the Dutch version of the SCNS-SF34 and newly
developed SCNS-HNC among HNC patients. Psychometric
properties assessed were content validity, factor structure, in-
ternal consistency, construct validity and test–retest reliability.
Content validity analyses of the SCNS-HNC showed that
there were no redundant items, but that some HNC issues may
need to be added, namely taste and olfaction, difficulty eating,
eating in company and changes in appetite, coughing and
breathlessness and mobility of the tongue. For some of these
problems, the need for SC was already addressed indirectly,
e.g. the problems on difficulty eating, eating in company and
changes in appetite were addressed partly by the question on
being informed about nutrition, and the problems on mobility
of the tongue is addressed by the question on chewing,
swallowing and speech. For the other problems/needs (taste
and olfaction and coughing and breathlessness), multidisci-
plinary discussions are needed on the necessity to update the
SCNS-HNC. In the present study, we aimed to include only
those problems/needs for which SC is available. However, we
realize that this aim is not consistent with the tenets of
supportive care needs assessment. One of the purposes is to
assist in identifying, guiding and designing the range of ser-
vices that ought to be available to patients [39]. Although an
item on taste and olfaction and on coughing and breathless-
ness may be added, the SCNS-HNC is a comprehensive
PROM.
Appropriateness of the SCNS-HNC was further supported
by the identified two-factor structure, namely HNC-specific
functioning, which comprises eight items on needs related to
HNC-specific functioning and problems, and a lifestyle do-
main, which comprises two items related to quitting smoking
and drinking. Internal consistency of HNC-specific function-
ing was good (Cronbach’s alpha = .89), while somewhat low
for the lifestyle domain (Cronbach’s alpha = .60), which can
be explained by the fact that this domain includes only two
items. We acknowledge that a domain with two items is gen-
erally recognized as less stable and thereby less reliable and
less construct valid than a domain with more items [40].
Regarding the SCNS-SF34, confirmatory factor analyses
showed that the five-factor structure of Boyes et al. [9] and
the four-factor structure of Au et al. [16] could not be repli-
cated in this study. Nevertheless, exploratory factor analyses
showed that the four-factor structure, in which item 19 is de-
leted, and the domains on health systems and information and
patient care and support were combined in one domain (i.e.
health system, information and patient support) [16], was the
best model for use in HNC patients with good internal
Table 4 Floor and ceiling effects
of the SCNS-HNC and suggested
factor structure in head and neck








HNC-specific functioning 21.3 1.0
1. Problems with chewing and or swallowing 47.0 8.0 .84
2. Problems with dry mouth and/or sticky mucus 36.0 10.0 .85
3. Problems with weight (underweight or overweight) 47.0 6.5 .74
4. To be informed on nutrition 57.5 5.0 .78
5. Difficulty speaking 54.8 5.0 .77
7. Problems with hearing 71.5 2.5 .59
8. Oral hygiene 56.6 4.5 .75
9. Problems with mobility of neck or shoulders 58.8 7.0 .70
Lifestyle 70.9 .5
10. Quit smoking 81.4 5.0 .84
11. Quit drinking 78.5 .5 .85
6. Care of your stoma and/or voice prosthesisb 20.0 30.0 – –
Eigenvalue 4.76 1.39
Variance 47.63 13.94
Cronbach’s α .89 .60
a Loadings >.3 are presented, and main (i.e. highest) loading is italicized
b Percentage of lowest score and percentage of highest score calculated for patients treatedwith total laryngectomyonly
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consistency (Cronbach’s alpha ranged from .79 to .95). Up till
now, this four-factor structure has only been proposed by Au
et al. [16]. Other validation studies proposed the (slightly ad-
justed) five-factor structure of Boyes et al. [9], although these
studies also acknowledged some difficulties or inconsistencies
when replicating the five-factor structure [11–13, 15, 17, 18].
Okuyama et al. [18], for instance, showed that items 21 and 22
had stronger cross loadings on the health system and informa-
tion domain, while originally allocated to the patient care and
support domain. The same holds for Lehmann et al. [13] who
found that item 30 had stronger cross loadings on the psycho-
logical domain, while originally allocated to the health care and
information domain. In addition, Schofield et al. [11] reported
that items 18 and 19 originally allocated to the patient care and
support domain did not load (loading <.30) to one of the do-
mains at all, and Doubova et al. [15] excluded item 31 due to
high cross loadings. Finally, Brédart et al. [12] and Li et al. [17],
the only two studies that performed confirmatory factor analy-
ses, reported that residuals were correlated indicating redundan-
cy among items. Based on these validation studies and our re-
sults, as already hypothesised by Li et al. [17], it can be assumed
that one universal factor structure for the SCNS-SF34 is unlike-
ly. The factor structure of the SCNS-SF34may potentially differ
regarding, for example, age, gender or cancer diagnosis.
To assess construct validity of both the SCNS-SF34 and the
SCNS-HNC, our study defined clear a priori hypotheses re-
garding the (magnitude of) correlation with other PROMs and
expected differences between groups of HNC patients. In our
study, 96 and 89 % of the hypothesised correlations were
found for the SCNS-SF34 and SCNS-HNC, respectively;
however, only 57 and 67 % respectively, showed the
hypothesised magnitude of correlation. In 11 of the 16 cases,
in which the correlation as such was supported but not the
magnitude of correlation, a stronger correlation was found
than a priori hypothesised based on previous validation stud-
ies [9, 11–13, 16, 18] and researchers’ expectations.
Regarding discriminative construct validity, patients treated
with multi-modality treatment in our study reported higher
levels of physical and daily living and psychological needs,
and patients long after treatment reported less health system,
information and patient support needs. No significant differ-
ences in SC needs were found between different gender and
age groups. This is in contrast to previous studies which have
repeatedly shown such differences [12, 13, 16–18, 35].
A possible explanation for the stronger correlations and ab-
sence of differences in SC needs regarding age and gender is that
all patients included in our study were at least 3 months after
treatment and, in general, had low levels of SC needs, as shown
by the high floor effects of 21.1–70.9%. These high floor effects
may have resulted in limited variation in outcomes and conse-
quently in higher correlations and the absence of differences
between groups. Another explanation may be that SC needs
are different in HNC patients compared to other cancer popula-
tions (i.e. breast, prostate and mixed cancer populations) on
which our hypotheses were mainly based [9, 11–13, 16, 18,
34, 35]. Our results are in line with the results of Henry et al.
whichwas published after our hypotheses formulation [23], who
found relatively high correlations between total SCNS-SF34
score and HADS-D and HADS-A of r = .44 and .53 and no
association with gender and age in HNC patients.
Table 5 Differences in SCNS-SF34 domain scores between different patient groups
Characteristics Number SCNS domain
Physical and daily





Health system, information and
patient support (n = 199)
Median (range) p value Median (range) p value Median (range) p value Median (range) p value
Age
18–60 years 63 7.5 (0–92.5) 0 (0–75.0) 13.3 (0–83.3)
>60 years 138 10.0 (0–85.0) 0 (0–100.0) 15.0 (0–91.7)
Gender .11 .67 .55
Male 134 10.0 (0–95.0) 10.0 (0–92.5) 0 (0–100.0)
Female 67 12.5 (0–95.0) 10.0 (0–85.0) 0 (0–66.7)
Treatment procedure .02 .01 .07
Single treatment 92 5.0 (0–95.0) 5.0 (0–85.0) 11.7 (0–85.0)
Multi modality treatment 109 10.0 (0–95.0) 15.0 (0–92.5) 18.3 (0–91.7)
Time since last treatment .02
0–1 year 78 19.2 (0–91.7)
1–2 years 60 13.3 (0–81.7)
>2 years 63 7.5 (0–76.7)
Significant differences are italicized
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Finally, test–retest reliability of the SCNS-SF34 and
SCNS-HNC was overall shown to be good (ICC ranged from
.67 to .83). Only two previous validation studies [12, 15] also
assessed test–retest reliability of the SCNS-SF34. They also
showed good test–retest reliability, except for the physical and
daily living domain in breast cancer patients [12].
A limitation of this study is that we included HNC patients
after treatment, limiting generalizability to HNC patients un-
dergoing treatment or other Dutch cancer populations.
Therefore, we encourage the validation of the SCNS-SF34
and SCNS-HNC in patients during treatment and other
Dutch cancer populations. Another limitation of this study is
that although patients were asked to report any additional
needs not yet included in the SCNS-HNC, patients did not
participate in the developmental stage by interview or focus
group. Also, critical review to assess whether all of the items
were relevant for the construct being measured and cognitive
interviews to determine how the items were perceived or un-
derstood byHNC patients were not performed.Main strengths
of this study are the development of the SCNS-HNC, which
can be used in conjunction with the SCNS-SF34, and the
assessment of a wide range of psychometric characteristics
including content validity, factor structure, internal consisten-
cy, construct validity and test–retest reliability.
Conclusion
In this study, a module was developed for use in conjunction
with the SCNS-SF34 that measures SC needs specific for
HNC patients (i.e. SCNS-HNC). The SCNS-SF34 and
SCNS-HNC are valid and reliable PROMs to evaluate the
need for SC among HNC patients. More research on the val-
idation of the SCNS-SF34 and SCNS-HNC in other popula-
tions, including HNC patients undergoing treatment is, how-
ever, warranted.
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